Novel Therapeutic Approach To Treat Alzheimer's Disease

إنتهاج إسلوباً جديد لعلاج مرض الزهايمر

Whole-brain hemisphere sections of Alzheimer's mice, the model APP/PSEN1, before and after treatment with the NAD+ booster Nicotinamide riboside (NR). The beta-amyloid plaque content in the brain of the APP/PSEN1 mice (left), clearly visible by Thioflavin S staining in green color and associated to brain damage during the disease, is reduced after 10 weeks treatment with NR (right). Credit: Vincenzo Sorrentino, Mario Romani, Francesca Potenza/EPFL مقطع من دماغ الفئران قبل وبعد العلاج، ويظهر (على اليسار) تناقصاً واضحاً في تراكم لويحات البيتا أميلويد بعد العلاج بالنيكوتيناميد ريبوزيد. Credit: Vincenzo Sorrentino, Mario Romani, Francesca Potenza/EPFL

العربية

Share: